tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
aTyr Pharma Reports Increased Losses Amid Rising R&D Costs
PremiumCompany AnnouncementsaTyr Pharma Reports Increased Losses Amid Rising R&D Costs
4M ago
aTyr Pharma reports Q3 EPS (26c), consensus (18c)
Premium
The Fly
aTyr Pharma reports Q3 EPS (26c), consensus (18c)
4M ago
aTyr Pharma Inc options imply 21.3% move in share price post-earnings
Premium
The Fly
aTyr Pharma Inc options imply 21.3% move in share price post-earnings
4M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
5M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
6M ago
Cautious Hold Rating for aTyr Pharma Amid Mixed Clinical Trial Results and Regulatory Uncertainty
Premium
Ratings
Cautious Hold Rating for aTyr Pharma Amid Mixed Clinical Trial Results and Regulatory Uncertainty
6M ago
3 Penny Stocks to Watch Now, 9/16/25
PremiumMarket News3 Penny Stocks to Watch Now, 9/16/25
6M ago
aTyr Pharma downgraded to Sector Perform from Outperform at RBC Capital
Premium
The Fly
aTyr Pharma downgraded to Sector Perform from Outperform at RBC Capital
6M ago
Wells Fargo downgrades aTyr Pharma on efzofitimod Phase 3 failure
Premium
The Fly
Wells Fargo downgrades aTyr Pharma on efzofitimod Phase 3 failure
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100